Invesco NASDAQ Future Gen 200 ETF
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
28.9%
1 yr return
87.3%
3 Yr Avg Return
16.4%
5 Yr Avg Return
N/A
Net Assets
$15.3 M
Holdings in Top 10
39.5%
52 WEEK LOW AND HIGH
$44.0
$25.06
$44.45
Expenses
OPERATING FEES
Expense Ratio 0.20%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
QQQS - Profile
Distributions
- YTD Total Return 28.9%
- 3 Yr Annualized Total Return 16.4%
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.6%
- Dividend Distribution Frequency Quarterly
Fund Details
-
Legal NameInvesco NASDAQ Future Gen 200 ETF
-
Fund Family NameINVESCOETF
-
Inception DateOct 13, 2022
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
Fund Description
The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index.
Strictly in accordance with its guidelines and mandated procedures, Nasdaq, Inc. (“Nasdaq” or the “Index Provider”) compiles, maintains and calculates the Underlying Index, which is comprised of securities of approximately 200 Nasdaq-listed, non-financial companies outside of the Nasdaq-100 Index® and Nasdaq Next Generation 100™ Index that have the most valuable portfolios of patents relative to their total market values, as estimated by a third-party data provider.
Securities are selected for inclusion in the Underlying Index based on the estimated value of their issuers’ patent portfolios, as determined by IPR Strategies, an independent data provider. IPR Strategies seeks to determine the potential value of an issuer by quantifying such issuer's intangible assets, such as its intellectual property and research and development activities, as represented by patents held by such issuer. To value a company’s patent portfolio, IPR Strategies utilizes a proprietary valuation model that takes into account patent data collected from multiple sources, including patent offices and corporate filings, as well as a variety of other economic data, including actual values from previously traded patents. The model then determines a “patent value estimate,” which represents the estimated dollar value of the portfolio of patents held by an issuer.
To be eligible for inclusion in the Underlying Index, a security must be a member of the Nasdaq Composite Index (a broad-based, capitalization-weighted index of all stocks listed on the Nasdaq) and must, among other criteria at the time of screening, have (i) traded for at least three calendar months on the Nasdaq Stock Market, New York Stock Exchange, NYSE American or Cboe BZX Exchange, (ii) a minimum full market capitalization of $100 million, and (iii) a minimum three-month average daily trading value of $1 million. The Underlying Index excludes securities of issuers included in the Nasdaq-100 Index® (an index that measures the performance of 100 of the largest Nasdaq-listed non-financial companies by market capitalization) and the Nasdaq Next Generation 100™Index (an index that measures the performance of the 100 largest Nasdaq-listed companies outside of the Nasdaq-100 Index® based on market capitalization). Securities eligible for inclusion in the Underlying Index may be of any capitalization (subject to the minimum $100 million threshold noted above), including small- and mid-cap companies. Security types generally eligible for inclusion in the Underlying Index include common stocks and American Depositary Receipts (“ADRs”) that represent securities of non-U.S. issuers. The Underlying Index may include companies from all major sectors, except for companies that are classified as “financials” according to the Industry Classification Benchmark (“ICB”).
All eligible issuers are ranked by the ratio of the company’s patent value estimate (as determined by IPR Strategies) to its market capitalization, and the securities of the 200 issuers with the largest ratios (i.e., those with larger patent portfolio values relative to their market capitalization) are included in the Underlying Index. The Underlying Index is an equally weighted index. “Equal weighting” means that the Underlying Index assigns each component security the same weight.
As of October 31, 2025, the Underlying Index was comprised of 198constituents with market capitalizations ranging from $100.1 million to $18.5 billion.
The Fund employs a “full replication” methodology in seeking to track the Underlying Index, meaning that the Fund generally invests in all of the securities comprising the Underlying Index in proportion to their weightings in the Underlying Index.
Concentration Policy. The Fund will concentrate its investments (i.e., invest more than 25% of the value of its net assets) in securities of issuers in any one industry or group of industries only to the extent that the Underlying Index reflects a concentration in that industry or group of industries. The Fund will not otherwise concentrate its investments in securities of issuers in any one industry or group of industries. As of August 31, 2025, the Fund had significant exposure to the health care and information technology sectors. The Fund's portfolio holdings, and the extent to which it concentrates its investments, are likely to change over time.
QQQS - Performance
Return Ranking - Trailing
| Period | QQQS Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 28.9% | N/A | N/A | N/A |
| 1 Yr | 87.3% | N/A | N/A | N/A |
| 3 Yr | 16.4%* | N/A | N/A | N/A |
| 5 Yr | N/A* | N/A | N/A | N/A |
| 10 Yr | N/A* | N/A | N/A | N/A |
* Annualized
Return Ranking - Calendar
| Period | QQQS Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 18.6% | N/A | N/A | N/A |
| 2024 | 9.3% | N/A | N/A | N/A |
| 2023 | -2.6% | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
Total Return Ranking - Trailing
| Period | QQQS Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 28.9% | N/A | N/A | N/A |
| 1 Yr | 87.3% | N/A | N/A | N/A |
| 3 Yr | 16.4%* | N/A | N/A | N/A |
| 5 Yr | N/A* | N/A | N/A | N/A |
| 10 Yr | N/A* | N/A | N/A | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | QQQS Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 23.0% | N/A | N/A | N/A |
| 2024 | 10.2% | N/A | N/A | N/A |
| 2023 | -1.9% | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
QQQS - Holdings
Concentration Analysis
| QQQS | Category Low | Category High | QQQS % Rank | |
|---|---|---|---|---|
| Net Assets | 15.3 M | N/A | N/A | N/A |
| Number of Holdings | 205 | N/A | N/A | N/A |
| Net Assets in Top 10 | 5.57 M | N/A | N/A | N/A |
| Weighting of Top 10 | 39.54% | N/A | N/A | N/A |
Top 10 Holdings
- Invesco Private Prime Fund 22.76%
- Invesco Private Government Fund 8.76%
- AXT, Inc. 1.67%
- Innovative Solutions and Support, Inc. 1.25%
- Allogene Therapeutics, Inc. 0.90%
- Neogen Corp. 0.88%
- Shattuck Labs, Inc. 0.88%
- Alector, Inc. 0.86%
- Entegris, Inc. 0.81%
- Vanda Pharmaceuticals Inc. 0.78%
Asset Allocation
| Weighting | Return Low | Return High | QQQS % Rank | |
|---|---|---|---|---|
| Stocks | 99.83% | N/A | N/A | N/A |
| Cash | 31.52% | N/A | N/A | N/A |
| Preferred Stocks | 0.00% | N/A | N/A | N/A |
| Other | 0.00% | N/A | N/A | N/A |
| Convertible Bonds | 0.00% | N/A | N/A | N/A |
| Bonds | 0.00% | N/A | N/A | N/A |
Stock Sector Breakdown
| Weighting | Return Low | Return High | QQQS % Rank | |
|---|---|---|---|---|
| Utilities | 0.00% | N/A | N/A | N/A |
| Technology | 0.00% | N/A | N/A | N/A |
| Real Estate | 0.00% | N/A | N/A | N/A |
| Industrials | 0.00% | N/A | N/A | N/A |
| Healthcare | 0.00% | N/A | N/A | N/A |
| Financial Services | 0.00% | N/A | N/A | N/A |
| Energy | 0.00% | N/A | N/A | N/A |
| Communication Services | 0.00% | N/A | N/A | N/A |
| Consumer Defense | 0.00% | N/A | N/A | N/A |
| Consumer Cyclical | 0.00% | N/A | N/A | N/A |
| Basic Materials | 0.00% | N/A | N/A | N/A |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | QQQS % Rank | |
|---|---|---|---|---|
| US | 99.83% | N/A | N/A | N/A |
| Non US | 0.00% | N/A | N/A | N/A |
QQQS - Expenses
Operational Fees
| QQQS Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.20% | N/A | N/A | N/A |
| Management Fee | 0.20% | N/A | N/A | N/A |
| 12b-1 Fee | N/A | N/A | N/A | N/A |
| Administrative Fee | N/A | N/A | N/A | N/A |
Sales Fees
| QQQS Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | N/A | N/A | N/A |
| Deferred Load | N/A | N/A | N/A | N/A |
Trading Fees
| QQQS Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | N/A | N/A | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| QQQS Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | N/A | N/A | N/A |
QQQS - Distributions
Dividend Yield Analysis
| QQQS | Category Low | Category High | QQQS % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.56% | N/A | N/A | N/A |
Dividend Distribution Analysis
| QQQS | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Quarterly |
Net Income Ratio Analysis
| QQQS | Category Low | Category High | QQQS % Rank | |
|---|---|---|---|---|
| Net Income Ratio | N/A | N/A | N/A | N/A |
Capital Gain Distribution Analysis
| QQQS | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Mar 23, 2026 | $0.061 | OrdinaryDividend |
| Dec 22, 2025 | $0.633 | OrdinaryDividend |
| Sep 22, 2025 | $0.399 | OrdinaryDividend |
| Jun 23, 2025 | $0.092 | OrdinaryDividend |
| Mar 24, 2025 | $0.061 | OrdinaryDividend |
| Dec 23, 2024 | $0.048 | OrdinaryDividend |
| Sep 23, 2024 | $0.114 | OrdinaryDividend |
| Mar 18, 2024 | $0.067 | OrdinaryDividend |
| Dec 18, 2023 | $0.037 | OrdinaryDividend |
| Sep 18, 2023 | $0.028 | OrdinaryDividend |
| Jun 20, 2023 | $0.036 | OrdinaryDividend |
| Mar 20, 2023 | $0.077 | OrdinaryDividend |
| Dec 19, 2022 | $0.011 | OrdinaryDividend |